Get the latest news, insights, and market updates on NAGE (Niagen Bioscience, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Niagen Bioscience Announces $10 Million Share Repurchase Program
LOS ANGELES, November 06, 2025--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Board of Directors has approved a share repurchase program under which the Company is authorized to repurchase up to $10 million of outstanding common stock over approximately 24 months (the "Program"). Nov 6, 2025 - $NAGE
Strong Q3 Results and Raised Guidance Might Change the Case for Investing in Niagen Bioscience (NAGE)
On November 4, 2025, Niagen Bioscience reported third quarter 2025 earnings, posting net sales of US$33.99 million and net income of US$4.58 million, with year-over-year growth in both revenue and profits. The company also reaffirmed its increased full-year 2025 net sales guidance, while expanding the distribution of NAD+-related therapies and launching initiatives to strengthen its digital and clinical presence. Now, we'll examine how Niagen Bioscience's better-than-expected quarterly... Nov 5, 2025 - $NAGE
3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value
As the U.S. market navigates through a complex landscape marked by fluctuating indices and ongoing concerns about an AI bubble, investors are keenly observing opportunities that may arise amidst the volatility. In such an environment, identifying stocks trading below their intrinsic value can be a strategic move, offering potential for growth as market conditions stabilize. Nov 5, 2025 - $NAGE
3 Stocks Estimated To Be Up To 46.5% Below Intrinsic Value
In recent days, major U.S. stock indexes have experienced sharp declines, with technology shares leading the downturn amid concerns about high valuations and broader market volatility. As investors navigate these turbulent times, identifying undervalued stocks can be an effective strategy for those seeking to capitalize on potential market inefficiencies. Understanding intrinsic value is crucial in this environment, as it allows investors to assess whether a stock is trading below its true... Nov 5, 2025 - $NAGE
Niagen Bioscience: Q3 Earnings Snapshot
LOS ANGELES (AP) — Niagen Bioscience, Inc. NAGE) on Tuesday reported net income of $4.6 million in its third quarter. On a per-share basis, the Los Angeles-based company said it had profit of 5 cents. Nov 4, 2025 - $NAGE
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple